3.2. Overall survival
The mean survival for the entire cohort was 12.88 ± 14.14 months, spanning from 0 days to 85.37 months. Furthermore, the estimated one-year survival rate for all patients was 45% (Figure 2). A notable disparity was observed upon gender-based analysis, with women demonstrating a more favorable one-year survival rate of 60% compared to men at 40%. Additionally, women exhibited significantly longer mean survival time, with an average of 16.14 ± 17.35 months, while men had a mean survival time of 10.75 ± 11.15 months (p = 0.023). Individuals over 60 experienced shorter mean survival times than their younger counterparts, with averages of 7.48 ± 7.06 months vs 15.9 ± 16.21 months, respectively. The age-dependent survival difference was highly statistically significant (p < 0.001). Moreover, patients aged 60 or younger demonstrated a significantly higher one-year survival rate compared to their older counterparts (75% vs. 35%)